Clinical Trial Update: Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung Adenocarcinoma

View source ↗

Summary

This clinical trial update examines the expression of optic atrophy type 1 (OPA1) protein in lung adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Snippet

Sponsor: China Medical University Hospital | Conditions: Lung Adenocarcinoma | Status: UNKNOWN